BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sturgeon CM, Sprague S, Almond A, Cavalier E, Fraser WD, Algeciras-Schimnich A, Singh R, Souberbielle JC, Vesper HW; IFCC Working Group for PTH. Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH. Clin Chim Acta 2017;467:42-7. [PMID: 27746210 DOI: 10.1016/j.cca.2016.10.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Dupuy AM, Bargnoux AS, Morena M, Lauret E, Souberbielle JC, Cavalier E, Cristol JP. Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice? Clin Chem Lab Med 2018;57:244-9. [PMID: 30183664 DOI: 10.1515/cclm-2018-0300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vissing Landgrebe A, Asp Vonsild Lund M, Lausten-Thomsen U, Frithioff-Bøjsøe C, Esmann Fonvig C, Lind Plesner J, Aas Holm L, Jespersen T, Hansen T, Christian Holm J. Population-based pediatric reference values for serum parathyroid hormone, vitamin D, calcium, and phosphate in Danish/North-European white children and adolescents. Clin Chim Acta 2021;523:483-90. [PMID: 34695445 DOI: 10.1016/j.cca.2021.10.024] [Reference Citation Analysis]
3 Zanchetta MB, Giacoia E, Jerkovich F, Fradinger E. Asymptomatic elevated parathyroid hormone level due to immunoassay interference. Osteoporos Int 2021. [PMID: 33893820 DOI: 10.1007/s00198-021-05950-2] [Reference Citation Analysis]
4 Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, DeLuca HF, Jones G, Munns CF, Bilezikian JP, Giustina A, Binkley N. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol. 2018;84:2194-2207. [PMID: 29851137 DOI: 10.1111/bcp.13652] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 24.0] [Reference Citation Analysis]
5 Young IS. The Enduring Importance and Challenge of Commutability. Clinical Chemistry 2018;64:421-3. [DOI: 10.1373/clinchem.2017.284216] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Miller WG, Budd J, Greenberg N, Weykamp C, Althaus H, Schimmel H, Panteghini M, Delatour V, Ceriotti F, Keller T, Hawkins D, Burns C, Rej R, Camara JE, MacKenzie F, van der Hagen E, Vesper H. IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure. Clin Chem 2020;66:769-78. [PMID: 32335671 DOI: 10.1093/clinchem/hvaa048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
7 Josephs RD, Martos G, Li M, Wu L, Melanson JE, Quaglia M, Beltrão PJ, Prevoo-franzsen D, Boeuf A, Delatour V, Öztug M, Henrion A, Jeong J, Park S. Establishment of measurement traceability for peptide and protein quantification through rigorous purity assessment—a review. Metrologia 2019;56:044006. [DOI: 10.1088/1681-7575/ab27e5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
8 Wang WH, Chen LW, Lee CC, Sun CY, Shyu YC, Hsu HR, Chien RN, Wu IW. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study. Biomed Res Int 2017;2017:7435657. [PMID: 28367447 DOI: 10.1155/2017/7435657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Cavalier E, Vasikaran S, Bhattoa HP, Heijboer AC, Makris K, Ulmer CZ. The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM. Clin Chim Acta 2021;515:44-51. [PMID: 33412144 DOI: 10.1016/j.cca.2020.12.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lunyera J, Scialla JJ. Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease. Semin Nephrol 2018;38:542-58. [PMID: 30413250 DOI: 10.1016/j.semnephrol.2018.08.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
11 Delgado JA, Bauça JM, Pastor MI, Barceló A. Use of data mining in the establishment of age-adjusted reference intervals for parathyroid hormone. Clin Chim Acta 2020;508:217-20. [PMID: 32417213 DOI: 10.1016/j.cca.2020.05.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Smit MA, van Kinschot CMJ, van der Linden J, van Noord C, Kos S. Clinical Guidelines and PTH Measurement: Does Assay Generation Matter? Endocrine Reviews 2019;40:1468-80. [DOI: 10.1210/er.2018-00220] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
13 Doelman UG, van Toor H, Uitterlinden P, van Ginhoven TM, Franssen GJ, van den Berg SAA. Use of a modified IDS-ISYS intact PTH assay for intraoperative PTH measurements. Clin Chem Lab Med 2020;58:e271-3. [PMID: 32412439 DOI: 10.1515/cclm-2020-0412] [Reference Citation Analysis]
14 Nyssen L, Fillet M, Cavalier E, Servais A. Highly sensitive and selective separation of intact parathyroid hormone and variants by sheathless CE‐ESI‐MS/MS. ELECTROPHORESIS 2019;40:1550-7. [DOI: 10.1002/elps.201800507] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
15 Bottani M, Banfi G, Guerra E, Locatelli M, Aarsand AK, Coşkun A, Díaz-Garzón J, Fernandez-Calle P, Sandberg S, Ceriotti F, González-Lao E, Simon M, Carobene A; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum biointact parathyroid hormone based on weekly samplings from 91 healthy participants. Ann Transl Med 2020;8:855. [PMID: 32793699 DOI: 10.21037/atm-19-4498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
16 Plebani M. Harmonization in laboratory medicine: more than clinical chemistry? Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:1579-86. [DOI: 10.1515/cclm-2017-0865] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
17 White CA, Sarabia S, Collier CP, McCudden C, Holden RM. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment. Clin Biochem 2021;94:62-6. [PMID: 33895125 DOI: 10.1016/j.clinbiochem.2021.04.018] [Reference Citation Analysis]
18 Gillery P, Young IS. Standardization: Recent achievements of the IFCC Scientific Division. Clinica Chimica Acta 2017;467:1-3. [DOI: 10.1016/j.cca.2016.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
19 Valcour A, Zierold C, Blocki FA, Hawkins DM, Martin KJ, Rao SD, Bonelli F. Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays. Clin Chem Lab Med 2018;56:1476-82. [PMID: 29750642 DOI: 10.1515/cclm-2018-0217] [Reference Citation Analysis]
20 Wójtowicz M, Piechota W, Wańkowicz Z, Smoszna J, Niemczyk S. Comparison of Second- and Third-Generation Parathyroid Hormone Test Results in Patients with Chronic Kidney Disease. Med Sci Monit 2020;26:e928301. [PMID: 33361742 DOI: 10.12659/MSM.928301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Lorenz K, Schneider R, Elwerr M. [Intraoperative measurement of parathyroid hormone in hyperparathyroidism]. Chirurg 2020;91:448-55. [PMID: 32052111 DOI: 10.1007/s00104-020-01123-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Yan C, Hu J, Yang J, Chen Z, Li H, Wei L, Zhang W, Xing H, Sang G, Wang X, Han R, Liu P, Li Z, Li Z, Huang Y, Jiang L, Li S, Dai S, Wang N, Yang Y, Ma L, Soh A, Beshiri A, Shen F, Yang T, Fan Z, Zheng Y, Chen W. Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: Sub-analysis from a prospective multicenter study. Clin Biochem 2018;54:32-6. [PMID: 29448045 DOI: 10.1016/j.clinbiochem.2018.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kakuta T, Ishida M, Fukagawa M. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders. Ther Apher Dial 2018;22:220-8. [PMID: 29781225 DOI: 10.1111/1744-9987.12690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]